Cognitive Decline: Environmental And Genetic Factors

This feed focuses on the role of environmental and genetic factors including environmental policies, disease susceptibility, and socioeconomic status on cognitive decline. Here is the latest research.

September 15, 2020

Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb

Journal of Parkinson's Disease
Aishwarya S KulkarniDaniel W Wesson
September 14, 2020

36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Hilkka Soininenthe LipiDiDiet clinical study group
September 12, 2020

Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study

European Journal of Radiology
Solveig TiepoltHenryk Barthel
September 13, 2020

Content of Home-Based Dementia Care: Adverse Consequences of Unmet Toileting Needs

Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society
Jennifer M ReckreyKatherine A Ornstein
September 17, 2020
Open Access

Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank

Journal of Neurology, Neurosurgery, and Psychiatry
Benjamin Meir JacobsAlastair J Noyce
September 13, 2020

Correction of microtubule defects within Aβ plaque-associated dystrophic axons results in lowered Aβ release and plaque deposition

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Yuemang YaoKurt R Brunden
September 8, 2020
Review
Open Access

A mixed methods systematic review of informal caregivers' experiences of fall risk among community-dwelling elders with dementia

Health & Social Care in the Community
Yuanjin ZhouNancy R Hooyman
September 6, 2020

Family History of Eating Disorder and the Broad Autism Phenotype in Autism

Autism Research : Official Journal of the International Society for Autism Research
Bianca A BarrionuevoMichael Cuccaro
September 16, 2020

Problematic gambling and criminal responsibility

L'Encéphale
M A GorsaneX Laqueille
September 18, 2020

Reducing Glut2 throughout the body does not result in cognitive behaviour differences in aged male mice

BMC Research Notes
Nicola MorriceCalum Sutherland
September 10, 2020

Is type 2 diabetes mellitus an inverse risk factor for the development of rheumatoid arthritis?

Journal of Human Genetics
Jun InamoTsutomu Takeuchi
September 16, 2020

Age-related changes in the immune system and cognitive disorders in vascular dementia and Alzheimer's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
M B Nuvakhova, S A Rachin
September 17, 2020
Open Access

Mouse Ataxin-2 Expansion Downregulates CamKII and Other Calcium Signaling Factors, Impairing Granule-Purkinje Neuron Synaptic Strength

International Journal of Molecular Sciences
Aleksandar ArsovićGeorg Auburger
September 13, 2020

A Pounding Problem: A Case of Recurrent Headache Caused by Anti-NMDA Receptor Encephalitis

The Journal of Emergency Medicine
Dylan NortonDavid Gill
September 8, 2020

Work-related experiences of people living with young-onset dementia in Japan

Health & Social Care in the Community
Satomi IkeuchiOsamu Iritani
September 10, 2020
Preprint
Open Access

Pro-drug peptide and its metabolites disrupt amyloid fibrils by destabilizing salt bridge interaction and planar beta-sheet topology

BioRxiv : the Preprint Server for Biology
A. VasistaK. Anki Reddy
September 6, 2020
Open Access

Impact of benzodiazepine consumption reduction on future burden of dementia

Scientific Reports
Hélène Jacqmin-GaddaPierre Joly
September 14, 2020

The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Mohamad HabesiSTAGING consortium, the Preclinical AD consortium, the ADNI, and the CARDIA studies

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/cognitive-decline-environmental-and-genetic/15132ad7-f227-467e-9ad1-51ecbb3ee9e0